InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
9
T+90 hit rate
30%
T+90 mean return
-5.6%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by REED ELIZABETH E, General Secretary. Officer active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 22 disclosures have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €284k. History available since 11 May 2021. The latest transaction was filed on 31 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations22 total
4,920 sharesCommon StockSEC:0001415889-25-012054:0
8,000 sharesCommon StockSEC:0001415889-25-003823:0
21,500 shares0Common StockSEC:0001415889-25-003066:0
2,437 shares@ US$19.4616.0% of flowCommon StockSEC:0001415889-25-002004:0
6,750 shares0Common StockSEC:0001415889-24-023095:0
25,000 shares0Common StockSEC:0001415889-24-002283:0
2,062 shares@ US$8.966.0% of flowCommon StockSEC:0001415889-24-001801:0
3,300 shares0Common StockSEC:0001209191-23-048256:0
825 shares@ US$16.594.4% of flowCommon StockSEC:0001209191-23-029012:0
20,250 shares0Common StockSEC:0001209191-23-006436:0
2,062 shares@ US$21.5014.3% of flowCommon StockSEC:0001209191-23-005035:0
900 shares@ US$21.510.0005% mcap10.9% of flowCommon StockSEC:0001209191-22-028708:0
9,840 shares0Common StockSEC:0001209191-22-006369:0
9,840 shares0Common StockSEC:0001209191-22-006369
2,250 shares@ US$24.980.0013% mcap29.4% of flowCommon StockSEC:0001209191-22-005081:0
2,250 shares@ US$24.980.0013% mcap65.9% of flowCommon StockSEC:0001209191-22-005081
5,000 shares0Common StockSEC:0001209191-22-003053
5,000 shares0Common StockSEC:0001209191-22-003053:0
4,500 shares0Common StockSEC:0001209191-21-052078:0
4,500 shares0Common StockSEC:0001209191-21-052078
1,625 shares@ US$19.1415.2% of flowCommon StockSEC:0001209191-21-032316
1,625 shares@ US$19.140.0006% mcap15.2% of flowCommon StockSEC:0001209191-21-032316:0
22 of 22 declarations
About REED ELIZABETH E
Elizabeth E. Reed is the Senior Vice President, General Counsel, and Corporate Secretary of Travere Therapeutics, Inc. She oversees the company's legal affairs and compliance. Her role is essential for ensuring legal protection and compliance.
